##
Fearon K,
Strasser F,
Anker SD,
Bosaeus I,
Bruera E,
Fainsinger RL et al. 2011. Definition and classification of cancer cachexia: an international consensus.
Lancet Oncol. 12(5):489-95. ##
Evans WJ,
Morley JE,
Argilés J,
Bales C,
Baracos V,
Guttridge D et al. 2008. Cachexia: a new definition.
Clin Nutr. 27(6):793-9. ## Inagaki J, Rodriguez V, Bodey GP. 1974. Proceedings: Causes of death in cancer patients. Cancer. 33:568–731. ##
Thomas DR. 2007. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia.
Clin Nutr. 26(4):389-99. ## Moley JF, Aamodt R, Rumble W, Kaye W, Norton JA. 1987. Body cell mass in cancer bearing and anorexia patients. J Parenter Enteral Nutr.11: 219–22.## Costa G, Lane WW, Vincint RG, Siebold JA, Aragon M, Bewley PT. 1980. Weight loss and cachexia in lung cancer. Nutr Cancer. 2:98–104.## Cervera J, Levine, RL. 1988. Modulation of the hydrophobicity of glutamine synthetase by mixed-function oxidation. FASEB J. 2: 2591–2595.##
Assi M,
Derbré F,
Lefeuvre-Orfila L,
Rébillard A. 2016. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
Free Radic Biol Med. 91:204-14. ## Charalabopoulos K, Kotsalos A, Batistatou A, Charalabopoulos A, Peschos D, Vezyraki P, et al. 2009. Serum and tissue selenium levels in gastric cancer patients and correlation with CEA. Anticancer Res. 29(8):3465–7. ## Schrauzer GN.2000. Anticarcinognic effects of selenium. CMLS, Cell Molec Life Sci. 57:1864–1873.## Shen Q, Zhang B, Xu R, Wang Y, Ding X, Li P. 2010. Antioxidant activity in vitro of the selenium-contained protein from the Se-enriched Bifidobacterium animalis 01. Anaerobe. 16:380–6.## Zhang J, Wang X, Xu T. 2007. Elemental selenium at nano size(Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 101:22–31.##
Yazdi MH,
Mahdavi M,
Varastehmoradi B,
Faramarzi MA,
Shahverdi AR. 2012. The immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an in vivo study. Biol Trace Elem Res.149(1):22-8##
Sengupta J,
Ghosh S,
Datta P,
Gomes A,
Gomes A. 2014. Physiologically important metal nanoparticles and their toxicity.
J Nanosci Nanotechnol. 14(1):990-1006.##
Jensen W,
Oechsle K,
Baumann HJ,
Mehnert A,
Klose H,
Bloch W et al. 2014. Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol.
Contemp Clin Trials. 37(1):120-8. ##
Lira FS,
Neto JC,
Seelaender M. 2014. Exercise training as treatment in cancer cachexia.
Appl Physiol Nutr Metab. 39(6):679-86. ##
Peternelj TT,
Coombes JS. 2011. Antioxidant supplementation during exercise training: beneficial or detrimental?
Sports Med. 1;41(12):1043-69.##
Powers SK,
Ji LL,
Leeuwenburgh C. 1999. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports Exerc. 31(7):987-97.##
Amani Shalamzari S,
Agha-Alinejad H,
Alizadeh S,
Shahbazi S,
Kashani Khatib Z,
Kazemi A et al. 2014. The effect of exercise training on the level of tissue IL-6 and vascular endothelial growth factor in breast cancer bearing mice. Iran J Basic Med Sci. 17(4): 231–258. ## Jones LW, Viglianti BL, Tashjian JA, Kothadia SM, Keir ST, Freedland SJ, et al. 2010. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol. 108: 343–348## Deacon Robert MJ. 2013. Measuring the Strength of Mice. J Vis Exp. (76): 2610. ##
Blum D,
Omlin A,
Baracos VE,
Solheim TS,
Tan BH,
Stone P et al. 2011. Cancercachexia: a systematicliteraturereview of items and domainsassociated with involuntaryweightloss in cancer.
Crit Rev Oncol Hematol. 80(1):114-44.## Vaughan, P. Martin, and P. A. Lewandowski. 2013. “Cancer cacheia: impact, mechanisms and emerging treatments,” Journal of Cachexia, Sarcopenia and Muscle. 4(2). 95–109.##
Prado CM,
Baracos VE,
McCargar LJ,
Mourtzakis M,
Mulder KE,
Reiman T, et al. 2007. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
Clin Cancer Res. 1;13(11):3264-8.##
Prado CM,
Baracos VE,
McCargar LJ,
Mourtzakis M,
Mulder KE,
Reiman T et al. 2007. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
Clin Cancer Res. 1;13(11):3264-8.## FearonKC. 2008. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 44, 1124–1132.## Del FabbroE, Hui D, DalalS, Dev R, Nooruddin ZI, Bruera E. 2011. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med. 14, 1004–1008.## Wigmore SJ, Plester CE, Ross JA, Fearon KC. 1997. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg. 84, 196–197.## Jayaprakash V, Marshall JR. 2011. Selenium and other antioxidants for chemoprevention of gastrointestinal cancers. Best Pract Res Clin Gastroenterol. 25-507-18.## Zeng H, Combs GF Jr. 2008. Selenium as an anticancer nutrient: rolls in cell proliferation and tumor cell invasion. J Nutr Biochem. 19(1):1-7.##
Chen GQ,
Mou CY,
Yang YQ,
Wang S,
Zhao ZW. 2011. Exercisetraining has beneficialanti-atrophyeffects by inhibitingoxidativestress-inducedMuRF1upregulation in rats with diabetes.
Life Sci. 4;89(1-2):44-9. ##
Benko I,
Nagy G,
Tanczos B,
Ungvari E,
Sztrik A,
Eszenyi P et al. 2012. Subacute toxicity of nano-selenium compared to other selenium species in mice.
Environ Toxicol Chem. 31(12):2812-20. ##
Yazdi MH,
Masoudifar M,
Varastehmoradi B,
Mohammadi E,
Kheradmand E,
Homayouni S et al. 2013. Effect of Oral Supplementation of Biogenic Selenium Nanoparticles on White Blood Cell Profile of BALB/c Mice and Mice Exposed to X-ray Radiation.
Avicenna J Med Biotechnol. 5(3):158-67.##
)